Health Biotech Limited
Health Biotech Limited
Sector 34A, Chandigarh
GST No. 04AABCH1876K1ZJ
TrustSEAL Verified
Call 08048737023 81% Response Rate
SEND EMAIL

Tocilizumab injection

There are very limited data on tocilizumab for persons with COVID-19 infection, and the optimal dosing is not known, especially when considering tocilizumab could be given in persons at different stages of COVID-19 disease severity. For this reason, the following provides detailed information regarding potential dosing of tocilizumab in persons with COVID-19.

Tocilizumab Injection

Tocilizumab Injection
  • Tocilizumab Injection
  • Tocilizumab Injection
Ask For Price
Product Price :Get Latest Price

Product Details:

ManufacturerHEALTH BIOTECH LIMITED
Prescription/Non prescriptionPrescription
Also givesThird Party Manufacturing
FormInjection
Country of OriginMade in India

There are very limited data on Tocilizumab for persons with COVID-19 infection, and the optimal dosing is not known, especially when considering tocilizumab could be given in persons at different stages of COVID-19 disease severity. For this reason, the following provides detailed information regarding potential dosing of tocilizumab in persons with COVID-19.
  • rheumatoid arthritis (a condition in which the body attacks its own joints, causing pain, swelling, and loss of function) in people who have not been helped by other disease-modifying antirheumatic drugs (DMARDs),
  • giant cell arteritis (a condition that causes swelling of blood vessels, especially in the scalp and head),
  • polyarticular juvenile idiopathic arthritis (PJIA; a type of childhood arthritis that affects five or more joints during the first six months of the condition, causing pain, swelling, and loss of function) in children 2 years of age or older.
  • systemic juvenile idiopathic arthritis (SJIA; a condition in children that causes inflammation in different areas of the body, causing fever, joint pain and swelling, loss of function, and delays in growth and development) in children 2 years of age or older,
  • cytokine release syndrome (a severe and possibly life-threatening reaction) that occurs in adults and children 2 years of age or older after receiving certain immunotherapy infusions.

Tocilizumab injection is in a class of medications called interleukin-6 (IL-6) receptor inhibitors. It works by blocking the activity of interleukin-6, a substance in the body that causes inflammation.

Tocilizumab 200mg/10ml Injection
Tocilizumab 400mg/20ml Injection



Request
Callback
Yes! I am Interested
X

Explore More Product



Reach Us
Gaurav Chawla
Health Biotech Limited
S.C.O. 162-164, Indian Airlines Building, Top Floor
Sector 34A, Chandigarh - 160022, India


Call Us


Send E-mailSend SMS